• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将 SV40ER 和 hTERT 导入乳腺球体可产生具有干细胞特性的乳腺癌细胞。

Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.

机构信息

Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, Karnataka, India.

出版信息

Oncogene. 2012 Apr 12;31(15):1896-909. doi: 10.1038/onc.2011.378. Epub 2011 Aug 29.

DOI:10.1038/onc.2011.378
PMID:21874052
Abstract

Emerging evidence suggests that cancers arise in stem/progenitor cells. Yet, the requirements for transformation of these primitive cells remains poorly understood. In this study, we have exploited the 'mammosphere' system that selects for primitive mammary stem/progenitor cells to explore their potential and requirements for transformation. Introduction of Simian Virus 40 Early Region and hTERT into mammosphere-derived cells led to the generation of NBLE, an immortalized mammary epithelial cell line. The NBLEs largely comprised of bi-potent progenitors with long-term self-renewal and multi-lineage differentiation potential. Clonal and karyotype analyses revealed the existence of heterogeneous population within NBLEs with varied proliferation, differentiation and sphere-forming potential. Significantly, injection of NBLEs into immunocompromised mice resulted in the generation of invasive ductal adenocarcinomas. Further, these cells harbored a sub-population of CD44(+)/CD24(-) fraction that alone had sphere- and tumor-initiating potential and resembled the breast cancer stem cell gene signature. Interestingly, prolonged in vitro culturing led to their further enrichment. The NBLE cells also showed increased expression of stemness and epithelial to mesenchymal transition markers, deregulated self-renewal pathways, activated DNA-damage response and cancer-associated chromosomal aberrations-all of which are likely to have contributed to their tumorigenic transformation. Thus, unlike previous in vitro transformation studies that used adherent, more differentiated human mammary epithelial cells our study demonstrates that the mammosphere-derived, less-differentiated cells undergo tumorigenic conversion with only two genetic elements, without requiring oncogenic Ras. Moreover, the striking phenotypic and molecular resemblance of the NBLE-generated tumors with naturally arising breast adenocarcinomas supports the notion of a primitive breast cell as the origin for this subtype of breast cancer. Finally, the NBLEs represent a heterogeneous population of cells with striking plasticity, capable of differentiation, self-renewal and tumorigenicity, thus offering a unique model system to study the molecular mechanisms involved with these processes.

摘要

新出现的证据表明,癌症起源于干细胞/祖细胞。然而,这些原始细胞转化的要求仍知之甚少。在这项研究中,我们利用了“乳腺球体”系统来选择原始的乳腺干细胞/祖细胞,以探索它们的潜力和转化的要求。将猴病毒 40 早期区和 hTERT 导入乳腺球体衍生的细胞中,导致了 NBLE 的产生,这是一种永生化的乳腺上皮细胞系。NBLE 主要由具有长期自我更新和多谱系分化潜力的双潜能祖细胞组成。克隆和核型分析显示,NBLE 内存在具有不同增殖、分化和球体形成能力的异质群体。重要的是,将 NBLE 注射到免疫缺陷小鼠中会导致侵袭性导管腺癌的产生。此外,这些细胞还存在一个 CD44(+)/CD24(-)亚群,该亚群仅具有球体和肿瘤起始能力,并且类似于乳腺癌干细胞的基因特征。有趣的是,体外长期培养会导致其进一步富集。NBLE 细胞还表现出更高的干性和上皮间质转化标志物的表达、失调的自我更新途径、激活的 DNA 损伤反应和与癌症相关的染色体异常——所有这些都可能促成了它们的肿瘤转化。因此,与之前使用贴壁、更分化的人乳腺上皮细胞的体外转化研究不同,我们的研究表明,乳腺球体衍生的、分化程度较低的细胞在仅需要两个遗传元件的情况下发生肿瘤转化,而不需要致癌 Ras。此外,NBLE 产生的肿瘤与自然发生的乳腺腺癌在表型和分子上惊人的相似,支持了原始乳腺细胞是这种乳腺癌亚型起源的观点。最后,NBLE 代表了具有惊人可塑性的细胞异质性群体,能够分化、自我更新和致瘤,因此为研究这些过程涉及的分子机制提供了一个独特的模型系统。

相似文献

1
Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.将 SV40ER 和 hTERT 导入乳腺球体可产生具有干细胞特性的乳腺癌细胞。
Oncogene. 2012 Apr 12;31(15):1896-909. doi: 10.1038/onc.2011.378. Epub 2011 Aug 29.
2
Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.鉴定乳腺癌干细胞/祖细胞的 HER2/neu 状态和转移潜能。
Ann Surg Oncol. 2010 Feb;17(2):613-23. doi: 10.1245/s10434-009-0730-z. Epub 2009 Oct 17.
3
Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit.由猿猴病毒40大T抗原或端粒酶催化亚基永生化的人乳腺上皮细胞的比较
Oncogene. 2002 Jan 3;21(1):128-39. doi: 10.1038/sj.onc.1205014.
4
Hormones and progeny of breast tumor cells.乳腺肿瘤细胞的激素及子代细胞
Climacteric. 2006 Apr;9(2):88-107. doi: 10.1080/13697130600677435.
5
Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.端粒酶永生化的非恶性人前列腺上皮细胞保留了多能干细胞的特性。
Exp Cell Res. 2008 Jan 1;314(1):92-102. doi: 10.1016/j.yexcr.2007.08.011. Epub 2007 Aug 23.
6
c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.c-Kit 对于 BRCA1 突变相关乳腺癌的起源细胞的生长和存活是必需的。
Oncogene. 2012 Feb 16;31(7):869-83. doi: 10.1038/onc.2011.289. Epub 2011 Jul 18.
7
CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.CD44(+)/CD24(-/low) 癌症干细胞/祖细胞在三阴性浸润性乳腺癌表型中更为丰富,并与不良预后相关。
Hum Pathol. 2012 Mar;43(3):364-73. doi: 10.1016/j.humpath.2011.05.005. Epub 2011 Aug 10.
8
Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer.卵巢癌自我更新和致瘤分化的肿瘤内异质性。
Stem Cells. 2012 Mar;30(3):415-24. doi: 10.1002/stem.1029.
9
Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.重叠基因可能控制小鼠体细胞重编程为诱导多能干细胞(iPSC)以及乳腺癌干细胞的过程。
In Silico Biol. 2010;10(5-6):207-21. doi: 10.3233/ISB-2010-0437.
10
RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.RANK 诱导人乳腺上皮细胞发生上皮-间充质转化和干细胞特性,并促进肿瘤发生和转移。
Cancer Res. 2012 Jun 1;72(11):2879-88. doi: 10.1158/0008-5472.CAN-12-0044. Epub 2012 Apr 10.

引用本文的文献

1
Derivation of the Immortalized Cell Line UM51-PrePodo-hTERT and Its Responsiveness to Angiotensin II and Activation of the RAAS Pathway.UM51-PrePodo-hTERT 永生化细胞系的构建及其对血管紧张素 II 的反应和 RAAS 途径的激活。
Cells. 2023 Jan 17;12(3):342. doi: 10.3390/cells12030342.
2
Tumor Cell-Intrinsic CD96 Mediates Chemoresistance and Cancer Stemness by Regulating Mitochondrial Fatty Acid β-Oxidation.肿瘤细胞内在 CD96 通过调节线粒体脂肪酸 β-氧化介导化疗耐药和癌症干性。
Adv Sci (Weinh). 2023 Mar;10(7):e2202956. doi: 10.1002/advs.202202956. Epub 2022 Dec 29.
3
AMP-activated protein kinase promotes breast cancer stemness and drug resistance.
AMP 激活的蛋白激酶促进乳腺癌干细胞特性和耐药性。
Dis Model Mech. 2022 Jun 1;15(6). doi: 10.1242/dmm.049203. Epub 2022 May 27.
4
Establishment and characterization of immortalized sweat gland myoepithelial cells.建立并鉴定永生化汗腺肌上皮细胞。
Sci Rep. 2022 Jan 7;12(1):7. doi: 10.1038/s41598-021-03991-5.
5
Roles Played by YY1 in Embryonic, Adult and Cancer Stem Cells.YY1 在胚胎细胞、成体细胞和肿瘤干细胞中的作用。
Stem Cell Rev Rep. 2021 Oct;17(5):1590-1606. doi: 10.1007/s12015-021-10151-9. Epub 2021 Mar 17.
6
Extra-telomeric functions of telomerase in the pathogenesis of Epstein-Barr virus-driven B-cell malignancies and potential therapeutic implications.端粒酶在爱泼斯坦-巴尔病毒驱动的B细胞恶性肿瘤发病机制中的端粒外功能及潜在治疗意义
Infect Agent Cancer. 2018 Apr 10;13:14. doi: 10.1186/s13027-018-0186-5. eCollection 2018.
7
The viable circulating tumor cells with cancer stem cells feature, where is the way out?具有肿瘤干细胞特征的存活循环肿瘤细胞,出路在哪里?
J Exp Clin Cancer Res. 2018 Feb 26;37(1):38. doi: 10.1186/s13046-018-0685-7.
8
Telomere and Telomerase Therapeutics in Cancer.癌症中的端粒与端粒酶疗法
Genes (Basel). 2016 May 26;7(6):22. doi: 10.3390/genes7060022.
9
Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance.药物转运体ABCC3在乳腺癌化疗耐药中的作用
PLoS One. 2016 May 12;11(5):e0155013. doi: 10.1371/journal.pone.0155013. eCollection 2016.
10
STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody.肿瘤微环境中由信号转导与转录激活因子3(STAT3)介导的胰岛素样生长因子2(IGF-2)分泌引发了对抗胰岛素样生长因子1受体(IGF-1R)抗体的天然抗性。
Nat Commun. 2015 Oct 14;6:8499. doi: 10.1038/ncomms9499.